Inosipranol 500 mg and 1000 mg powder for oral solution

Inosipranol is indicated for the treatment or response to suppressed or impaired cellular immunity and the clinical symptoms associated with:
• Influenza and other viral infections of the respiratory tract, primary and secondary to immunosuppressive conditions.
• Infections caused by herpes viruses: herpes simplex virus type 1 and 2 (herpes simplex virus, HSV), varicella-zoster virus (varicella-zoster virus, VZV), infections caused by cytomegalovirus (CMV) and Epstein-Barr virus (EBV).
• Genital warts (condyloma accuminata) – external lesions (except perianal or meatal localization) as monotherapy or as an adjunct to conventional local or surgical procedures.
• Mucocutaneous, vulvovaginal (subclinical manifestation) or endocervical-associated human papillomavirus (HPV) infections.
• Viral hepatitis.
• Measles /severe or complicated infection/.
• Mumps.
• Subacute sclerosing panencephalitis (SSPE).
• Viral aphthous stomatitis.